Stephen Hoge

Track

Insider profile

Currently holds a position at Moderna Inc

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 48% 68% 82%
Transactions
34 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
President Moderna Inc Feb. 1, 2015 -
Stephen Hoge's trades of Moderna Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-16 2026-07-15
US Moderna Inc (MRNA)
PlS Planned sale
67,588 -37.4%
333.13
US$666,796 		67,588 -37.4% 333.13 US$666,796
2026-07-15 2026-07-15
US Moderna Inc (MRNA)
PrS Proposed sale
86,081
373.62
US$3,897,463 		86,081 373.62 US$3,897,463
2026-06-17 2026-06-15
US Moderna Inc (MRNA)
PlS Planned sale
20,841 -29.6%
85.22
US$3,431,856 		20,841 -29.6% 85.22 US$3,431,856
2026-06-15 2026-06-15
US Moderna Inc (MRNA)
PrS Proposed sale
53,336
51.37
US$2,739,870 		53,336 51.37 US$2,739,870
2026-05-18 2026-05-15
US Moderna Inc (MRNA)
PlS Planned sale
53,336 -3.5%
48.40
US$2,581,462 		53,336 -3.5% 48.40 US$2,581,462
2026-05-15 2026-05-15
US Moderna Inc (MRNA)
PrS Proposed sale
53,336
48.40
US$2,581,462 		53,336 48.40 US$2,581,462
2026-02-25 2026-02-23
US Moderna Inc (MRNA)
PlS Planned sale
160,009 -9.9%
48.84
US$7,814,840 		160,009 -9.9% 48.84 US$7,814,840
2026-02-23 2026-02-23
US Moderna Inc (MRNA)
PrS Proposed sale
160,009
48.84
US$7,814,840 		160,009 48.84 US$7,814,840
2024-12-04 2024-12-03
US Moderna Inc (MRNA)
S Sale
314 -0.0%
43.30
US$13,595 		314 -0.0% 43.30 US$13,595
2024-12-03 2024-12-03
US Moderna Inc (MRNA)
PrS Proposed sale
314
43.30
US$13,595 		314 43.30 US$13,595
2024-12-02 2024-11-29
US Moderna Inc (MRNA)
S Sale
291 -0.0%
42.79
US$12,452 		291 -0.0% 42.79 US$12,452
2024-11-29 2024-11-29
US Moderna Inc (MRNA)
PrS Proposed sale
291
42.79
US$12,452 		291 42.79 US$12,452
2024-11-12 2024-11-11
US Moderna Inc (MRNA)
PrS Proposed sale
277
46.10
US$12,771 		277 46.10 US$12,771
2024-11-12 2024-11-11
US Moderna Inc (MRNA)
S Sale
277 -0.0%
46.10
US$12,771 		277 -0.0% 46.10 US$12,771
2024-09-04 2024-09-03
US Moderna Inc (MRNA)
S Sale
318 -0.0%
76.99
US$24,483 		318 -0.0% 76.99 US$24,483
2024-09-03 2024-09-03
US Moderna Inc (MRNA)
PrS Proposed sale
318
76.99
US$24,482 		318 76.99 US$24,482
2024-08-30 2024-08-29
US Moderna Inc (MRNA)
S Sale
300 -0.0%
78.03
US$23,408 		300 -0.0% 78.03 US$23,408
2024-08-29 2024-08-29
US Moderna Inc (MRNA)
PrS Proposed sale
300
78.03
US$23,408 		300 78.03 US$23,408
2024-08-13 2024-08-12
US Moderna Inc (MRNA)
S Sale
254 -0.0%
84.10
US$21,363 		254 -0.0% 84.10 US$21,363
2024-08-12 2024-08-12
US Moderna Inc (MRNA)
PrS Proposed sale
254
84.10
US$21,363 		254 84.10 US$21,363
2024-07-16 2024-07-15
US Moderna Inc (MRNA)
PlS Planned sale
15,000 -1.0%
121.12
US$1,816,800 		15,000 -1.0% 121.12 US$1,816,800
2024-07-15 2024-07-15
US Moderna Inc (MRNA)
PrS Proposed sale
15,000
121.12
US$1,816,800 		15,000 121.12 US$1,816,800
2024-06-18 2024-06-17
US Moderna Inc (MRNA)
PlS Planned sale
15,000 -1.0%
138.16
US$2,072,400 		15,000 -1.0% 138.16 US$2,072,400
2024-06-17 2024-06-17
US Moderna Inc (MRNA)
PrS Proposed sale
15,000
138.16
US$2,072,400 		15,000 138.16 US$2,072,400
2024-06-04 2024-06-03
US Moderna Inc (MRNA)
S Sale
339 -0.0%
140.72
US$47,704 		339 -0.0% 140.72 US$47,704
2024-06-03 2024-06-03
US Moderna Inc (MRNA)
PrS Proposed sale
339
140.72
US$47,704 		339 140.72 US$47,704
2024-05-30 2024-05-29
US Moderna Inc (MRNA)
S Sale
341 -0.0%
144.50
US$49,276 		341 -0.0% 144.50 US$49,276
2024-05-29 2024-05-29
US Moderna Inc (MRNA)
PrS Proposed sale
341
144.50
US$49,276 		341 144.50 US$49,276
2024-05-17 2024-05-15
US Moderna Inc (MRNA)
PlS Planned sale
15,000 -1.0%
127.49
US$1,912,350 		15,000 -1.0% 127.49 US$1,912,350
2024-05-15 2024-05-15
US Moderna Inc (MRNA)
PrS Proposed sale
15,000
127.49
US$1,912,350 		15,000 127.49 US$1,912,350
2024-05-13 2024-05-10
US Moderna Inc (MRNA)
S Sale
255 -0.0%
120.96
US$30,844 		255 -0.0% 120.96 US$30,844
2024-05-10 2024-05-10
US Moderna Inc (MRNA)
PrS Proposed sale
255
120.96
US$30,844 		255 120.96 US$30,844
2024-04-16 2024-04-15
US Moderna Inc (MRNA)
PlS Planned sale
15,000 -1.0%
105.02
US$1,575,300 		15,000 -1.0% 105.02 US$1,575,300
2024-04-15 2024-04-15
US Moderna Inc (MRNA)
PrS Proposed sale
15,000
105.02
US$1,575,300 		15,000 105.02 US$1,575,300
2024-03-19 2024-03-15
US Moderna Inc (MRNA)
PlS Planned sale
15,000 -1.0%
103.17
US$1,547,550 		15,000 -1.0% 103.17 US$1,547,550
2024-03-15 2024-03-15
US Moderna Inc (MRNA)
PrS Proposed sale
15,000
103.17
US$1,547,550 		15,000 103.17 US$1,547,550
2024-03-05 2024-03-04
US Moderna Inc (MRNA)
S Sale
309 -0.0%
94.34
US$29,151 		309 -0.0% 94.34 US$29,151
2024-03-04 2024-03-04
US Moderna Inc (MRNA)
PrS Proposed sale
309
94.34
US$29,151 		309 94.34 US$29,151
2024-03-01 2024-02-29
US Moderna Inc (MRNA)
S Sale
2,388 -0.2%
94.57
US$225,838 		2,388 -0.2% 94.57 US$225,838
2024-02-29 2024-02-29
US Moderna Inc (MRNA)
PrS Proposed sale
2,388
94.57
US$225,838 		2,388 94.57 US$225,838
2024-02-23 2024-02-22
US Moderna Inc (MRNA)
PlS Planned sale
15,000 -1.0%
100.00
US$1,500,000 		15,000 -1.0% 100.00 US$1,500,000
2024-02-22 2024-02-22
US Moderna Inc (MRNA)
PrS Proposed sale
15,000
10.00
US$150,000 		15,000 10.00 US$150,000
2024-02-16 2024-02-16
US Moderna Inc (MRNA)
PrS Proposed sale
10,542
88.88
US$936,981 		10,542 88.88 US$936,981
2024-02-16 2024-02-16
US Moderna Inc (MRNA)
S Sale
10,542 -0.7%
88.88
US$936,981 		10,542 -0.7% 88.88 US$936,981
2024-02-13 2024-02-12
US Moderna Inc (MRNA)
S Sale
304 -0.0%
86.23
US$26,214 		304 -0.0% 86.23 US$26,214